Last update 08 May 2025

CAR adjuvant

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesRespiratory DiseasesOther Diseases
Active Indication
COVID-19Hypertension, PulmonarySepsis
Inactive Indication-
Originator Organization
Vascular BioSciences, Inc.Vascular BioSciences, Inc.
Active Organization
Vascular BioSciences, Inc.Vascular BioSciences, Inc.
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with CAR adjuvant
Login to view more data
100 Translational Medicine associated with CAR adjuvant
Login to view more data
100 Patents (Medical) associated with CAR adjuvant
Login to view more data
100 Deals associated with CAR adjuvant
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 1
United States
Vascular BioSciences, Inc.Vascular BioSciences, Inc.
12 Jan 2022
Hypertension, PulmonaryPhase 1
United States
Vascular BioSciences, Inc.Vascular BioSciences, Inc.
12 Jan 2022
SepsisPhase 1
United States
Vascular BioSciences, Inc.Vascular BioSciences, Inc.
12 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ASCO2007
Not Applicable
Glioblastoma
Adjuvant
80
Radiation therapy + concurrent temozolomide + rotational multi-agent chemotherapy
(pxunitbqwb) = admszmulpd kvyiqnukvs (qyruglpkpn, 49% - 71%)
-
20 Jun 2007
(pxunitbqwb) = zaxdmahkhs kvyiqnukvs (qyruglpkpn, 23% - 43%)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free